BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 18398482)

  • 1. The role of the iron transporter ABCB7 in refractory anemia with ring sideroblasts.
    Boultwood J; Pellagatti A; Nikpour M; Pushkaran B; Fidler C; Cattan H; Littlewood TJ; Malcovati L; Della Porta MG; Jädersten M; Killick S; Giagounidis A; Bowen D; Hellström-Lindberg E; Cazzola M; Wainscoat JS
    PLoS One; 2008 Apr; 3(4):e1970. PubMed ID: 18398482
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The transporter ABCB7 is a mediator of the phenotype of acquired refractory anemia with ring sideroblasts.
    Nikpour M; Scharenberg C; Liu A; Conte S; Karimi M; Mortera-Blanco T; Giai V; Fernandez-Mercado M; Papaemmanuil E; Högstrand K; Jansson M; Vedin I; Wainscoat JS; Campbell P; Cazzola M; Boultwood J; Grandien A; Hellström-Lindberg E
    Leukemia; 2013 Apr; 27(4):889-896. PubMed ID: 23070040
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gene expression profiling of erythroblasts from refractory anaemia with ring sideroblasts (RARS) and effects of G-CSF.
    Nikpour M; Pellagatti A; Liu A; Karimi M; Malcovati L; Gogvadze V; Forsblom AM; Wainscoat JS; Cazzola M; Zhivotovsky B; Grandien A; Boultwood J; Hellström-Lindberg E
    Br J Haematol; 2010 Jun; 149(6):844-54. PubMed ID: 20408843
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mitochondrial ferritin expression in erythroid cells from patients with sideroblastic anemia.
    Cazzola M; Invernizzi R; Bergamaschi G; Levi S; Corsi B; Travaglino E; Rolandi V; Biasiotto G; Drysdale J; Arosio P
    Blood; 2003 Mar; 101(5):1996-2000. PubMed ID: 12406866
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Loss of ABCB7 gene: pathogenesis of mitochondrial iron accumulation in erythroblasts in refractory anemia with ringed sideroblast with isodicentric (X)(q13).
    Sato K; Torimoto Y; Hosoki T; Ikuta K; Takahashi H; Yamamoto M; Ito S; Okamura N; Ichiki K; Tanaka H; Shindo M; Hirai K; Mizukami Y; Otake T; Fujiya M; Sasaki K; Kohgo Y
    Int J Hematol; 2011 Mar; 93(3):311-318. PubMed ID: 21380928
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Refractory anemia with ring sideroblasts.
    Malcovati L; Cazzola M
    Best Pract Res Clin Haematol; 2013 Dec; 26(4):377-85. PubMed ID: 24507814
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Candidate gene mutation analysis in idiopathic acquired sideroblastic anemia (refractory anemia with ringed sideroblasts).
    Steensma DP; Hecksel KA; Porcher JC; Lasho TL
    Leuk Res; 2007 May; 31(5):623-8. PubMed ID: 16870250
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mitochondrial iron metabolism and sideroblastic anemia.
    Sheftel AD; Richardson DR; Prchal J; Ponka P
    Acta Haematol; 2009; 122(2-3):120-33. PubMed ID: 19907149
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnosis and treatment of sideroblastic anemias: from defective heme synthesis to abnormal RNA splicing.
    Cazzola M; Malcovati L
    Hematology Am Soc Hematol Educ Program; 2015; 2015():19-25. PubMed ID: 26637696
    [TBL] [Abstract][Full Text] [Related]  

  • 10. RNA silencing of the mitochondrial ABCB7 transporter in HeLa cells causes an iron-deficient phenotype with mitochondrial iron overload.
    Cavadini P; Biasiotto G; Poli M; Levi S; Verardi R; Zanella I; Derosas M; Ingrassia R; Corrado M; Arosio P
    Blood; 2007 Apr; 109(8):3552-9. PubMed ID: 17192393
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Growth differentiation factor 15 production is necessary for normal erythroid differentiation and is increased in refractory anaemia with ring-sideroblasts.
    Ramirez JM; Schaad O; Durual S; Cossali D; Docquier M; Beris P; Descombes P; Matthes T
    Br J Haematol; 2009 Jan; 144(2):251-62. PubMed ID: 19036111
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deregulation of genes related to iron and mitochondrial metabolism in refractory anemia with ring sideroblasts.
    del Rey M; Benito R; Fontanillo C; Campos-Laborie FJ; Janusz K; Velasco-Hernández T; Abáigar M; Hernández M; Cuello R; Borrego D; Martín-Zanca D; De Las Rivas J; Mills KI; Hernández-Rivas JM
    PLoS One; 2015; 10(5):e0126555. PubMed ID: 25955609
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD34+/CD36- cells from myelodysplasia patients have a limited capacity to proliferate but can differentiate in response to Epo and MGF stimulation.
    Brada SJ; de Wolf JT; Hendriks DW; Smit JW; Vellenga E
    Leukemia; 1998 Jun; 12(6):882-6. PubMed ID: 9639415
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aberrant mitochondrial iron distribution and maturation arrest characterize early erythroid precursors in low-risk myelodysplastic syndromes.
    Tehranchi R; Invernizzi R; Grandien A; Zhivotovsky B; Fadeel B; Forsblom AM; Travaglino E; Samuelsson J; Hast R; Nilsson L; Cazzola M; Wibom R; Hellström-Lindberg E
    Blood; 2005 Jul; 106(1):247-53. PubMed ID: 15755901
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Refractory cytopenia with multilineage dysplasia: further characterization of an 'unclassifiable' myelodysplastic syndrome.
    Rosati S; Mick R; Xu F; Stonys E; Le Beau MM; Larson R; Vardiman JW
    Leukemia; 1996 Jan; 10(1):20-6. PubMed ID: 8558932
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Erythroid precursors from patients with low-risk myelodysplasia demonstrate ultrastructural features of enhanced autophagy of mitochondria.
    Houwerzijl EJ; Pol HW; Blom NR; van der Want JJ; de Wolf JT; Vellenga E
    Leukemia; 2009 May; 23(5):886-91. PubMed ID: 19148135
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Refractory anemia with ring sideroblasts (RARS) and RARS with thrombocytosis: "2019 Update on Diagnosis, Risk-stratification, and Management".
    Patnaik MM; Tefferi A
    Am J Hematol; 2019 Apr; 94(4):475-488. PubMed ID: 30618061
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aberrant splicing of genes involved in haemoglobin synthesis and impaired terminal erythroid maturation in SF3B1 mutated refractory anaemia with ring sideroblasts.
    Conte S; Katayama S; Vesterlund L; Karimi M; Dimitriou M; Jansson M; Mortera-Blanco T; Unneberg P; Papaemmanuil E; Sander B; Skoog T; Campbell P; Walfridsson J; Kere J; Hellström-Lindberg E
    Br J Haematol; 2015 Nov; 171(4):478-90. PubMed ID: 26255870
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Refractory anemia with ring sideroblasts (RARS) and RARS with thrombocytosis (RARS-T): 2017 update on diagnosis, risk-stratification, and management.
    Patnaik MM; Tefferi A
    Am J Hematol; 2017 Mar; 92(3):297-310. PubMed ID: 28188970
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Different pathophysiological mechanisms of intramitochondrial iron accumulation in acquired and congenital sideroblastic anemia caused by mitochondrial DNA deletion.
    Matthes T; Rustin P; Trachsel H; Darbellay R; Costaridou S; Xaidara A; Rideau A; Beris P
    Eur J Haematol; 2006 Aug; 77(2):169-74. PubMed ID: 16856911
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.